More importantly, mice with tumors overexpressing P‐cadherin exhibited significantly shorter survival than mice injected with control GBM cells (P < 0.0001; Fig. 2P), suggesting P‐cadherin may be prognostically valuable in GBM. The gene discussed is CDH3; the disease is glioblastoma.